The first randomized trial comparing bone marrow and peripheral blood stem cells (PBSCs) as sources for hematopoietic stem cell transplants from unrelated donors suggests that caution may be needed when using PBSCs from unrelated donors to treat leukemia or related blood disorders. The results were published October 18 in the New England Journal of Medicine. Read more > >
Dr. Ted Trimble, director of NCI's Center for Global Health, discusses how the new center will work to reduce the global burden of cancer.
- In Memoriam: Dr. E. Donnall Thomas
- Board of Scientific Advisors to Meet November 5
- Cyber-Seminar: Adapting and Using Evidence-Based Programs with Community Partners
A MESSAGE TO READERS
Cancer Resources for Those Affected by Hurricane Sandy
Information is available to help cancer patients, physicians, and researchers who are in areas affected by recent storms.
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at email@example.com.